human menopausal gonadotrophin
PreclinicalSmall molecule
human menopausal gonadotrophin is one of 6 small molecule programs targeting Endometrial. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
6 competitors in Endometrial
#DrugCompanyPhaseTrials
1Cataflam
NovartisPreclinical
Orgalutran
OOrganon and Co
Preclinical
Human Chorionic Gonadotrophin
TThe Egyptian IVF-ET Center
Preclinical
Methoxyflurane - Penthrox
UUniversity of Manitoba
Preclinical
Specific Treatment
AAssistance Publique - Hôpitaux de Paris
Preclinical
human menopausal gonadotrophin
RReproductive & Genetic Hospital of CITIC-Xiangya
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
In Vitro Fertilization (IVF)1 trial
Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program
Completed·—·Phase 1·NCT02640976·216 enrolled
Endometrial1 trial
Sources
References
- [1]
- [2]
- [3]
- [4]
Details